GCM2 and familial isolated hyperparathyroidism: These observations, especially in an Israeli population where AJ patients with FIHP can occasionally (and apparently more than in the general population) carry the GCM2 p.Tyr394Ser variant, warrant further and larger studies to evaluate its penetrance and whether screening for its presence might have a useful role in clinical management.